_id
6913027cccc777a4e85d79a9
Ticker
IOBT
Name
IO Biotech Inc
Exchange
NASDAQ
Address
Ole MaalOees Vej 3, Copenhagen, Denmark, 2200
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.iobiotech.com
Description
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide to target T cells that recognize epitopes derived from Arginase 1, which is an immunoregulatory enzyme highly expressed in difficult-to-treat tumors associated with high levels of myeloid-derived suppressor cells, including renal cell carcinoma, head and neck, breast, pancreatic, ovarian, colorectal, and prostate cancers. In addition, the company develops IO170, a TGFß1 vaccine for the treatment of solid tumors. IO Biotech, Inc. was incorporated in 2014 and is based in Copenhagen, Denmark.
Last Close
0.8501
Volume
425977
Current Price
0.8076
Change
-4.999411833901892
Last Updated
2025-12-01T09:23:49.345Z
Image
data:image/webp;base64,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
Ipo Date
2021-11-05T00:00:00.000Z
Market Cap
51774388
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-0.20519999999999997
Sentiment Sources
5
Rating
4.4
Target Price
2.4633
Strong Buy
2
Buy
3
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
230000
Gross Profit
-230000
Operating Expenses
19125000
Operating Income
-19355000
Interest Expense
886000
Pretax Income
-10042000
Net Income
-8378000
Eps
-0.12515318492896324
Dividends Per Share
-
Shares Outstanding
71948842
Income Tax Expense
-1664000
EBITDA
-8926000
Operating Margin
-
Total Other Income Expense Net
9313000
Cash
30664000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
36831000
Property Plant Equipment
1846000
Total Assets
39956000
Payables
5587000
Short Term Debt
788000
Long Term Debt
16664000
Total Liabilities
39045000
Equity
911000
Depreciation
230000
Change In Working Capital
-2748000
Cash From Operations
-18478000
Capital Expenditures
4000
Cash From Investing
-4000
Cash From Financing
21270000
Net Change In Cash
2533000
PE
-
PB
59.34394086322722
ROE
-919.648737650933
ROA
-20.968064871358493
FCF
-18482000
Fcf Percent
-
Piotroski FScore
0
Health Score
16
Deep Value Investing Score
3
Defensive Investing Score
5
Dividend Investing Score
1
Economic Moat Investing Score
2.8
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
230000
Quarters > 0 > income Statement > gross Profit
-230000
Quarters > 0 > income Statement > operating Expenses
19125000
Quarters > 0 > income Statement > operating Income
-19355000
Quarters > 0 > income Statement > interest Expense
886000
Quarters > 0 > income Statement > pretax Income
-10042000
Quarters > 0 > income Statement > net Income
-8378000
Quarters > 0 > income Statement > eps
-0.12515318492896324
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
66941964
Quarters > 0 > income Statement > income Tax Expense
-1664000
Quarters > 0 > income Statement > EBITDA
-8926000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
9313000
Quarters > 0 > balance Sheet > cash
30664000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
36831000
Quarters > 0 > balance Sheet > property Plant Equipment
1846000
Quarters > 0 > balance Sheet > total Assets
39956000
Quarters > 0 > balance Sheet > payables
5587000
Quarters > 0 > balance Sheet > short Term Debt
788000
Quarters > 0 > balance Sheet > long Term Debt
16664000
Quarters > 0 > balance Sheet > total Liabilities
39045000
Quarters > 0 > balance Sheet > equity
911000
Quarters > 0 > cash Flow > net Income
-8378000
Quarters > 0 > cash Flow > depreciation
230000
Quarters > 0 > cash Flow > change In Working Capital
-2748000
Quarters > 0 > cash Flow > cash From Operations
-18478000
Quarters > 0 > cash Flow > capital Expenditures
4000
Quarters > 0 > cash Flow > cash From Investing
-4000
Quarters > 0 > cash Flow > cash From Financing
21270000
Quarters > 0 > cash Flow > net Change In Cash
2533000
Quarters > 0 > ratios > PE
-0.12515318492896324
Quarters > 0 > ratios > PB
59.34394086322722
Quarters > 0 > ratios > ROE
-919.648737650933
Quarters > 0 > ratios > ROA
-20.968064871358493
Quarters > 0 > ratios > FCF
-18482000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
16
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
234000
Quarters > 1 > income Statement > gross Profit
-234000
Quarters > 1 > income Statement > operating Expenses
22936000
Quarters > 1 > income Statement > operating Income
-23170000
Quarters > 1 > income Statement > interest Expense
253000
Quarters > 1 > income Statement > pretax Income
-26099000
Quarters > 1 > income Statement > net Income
-26217000
Quarters > 1 > income Statement > eps
-0.3979452986945506
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
65880914
Quarters > 1 > income Statement > income Tax Expense
118000
Quarters > 1 > income Statement > EBITDA
-25612000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-2929000
Quarters > 1 > balance Sheet > cash
28131000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1141000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
38980000
Quarters > 1 > balance Sheet > property Plant Equipment
2073000
Quarters > 1 > balance Sheet > total Assets
42326000
Quarters > 1 > balance Sheet > payables
5537000
Quarters > 1 > balance Sheet > short Term Debt
768000
Quarters > 1 > balance Sheet > long Term Debt
6720000
Quarters > 1 > balance Sheet > total Liabilities
40734000
Quarters > 1 > balance Sheet > equity
1592000
Quarters > 1 > cash Flow > net Income
-26217000
Quarters > 1 > cash Flow > depreciation
234000
Quarters > 1 > cash Flow > change In Working Capital
1340000
Quarters > 1 > cash Flow > cash From Operations
-19822000
Quarters > 1 > cash Flow > capital Expenditures
26000
Quarters > 1 > cash Flow > cash From Investing
-26000
Quarters > 1 > cash Flow > cash From Financing
11487000
Quarters > 1 > cash Flow > net Change In Cash
-8955000
Quarters > 1 > ratios > PE
-0.3979452986945506
Quarters > 1 > ratios > PB
33.42049381055276
Quarters > 1 > ratios > ROE
-1646.7964824120604
Quarters > 1 > ratios > ROA
-61.94065113641734
Quarters > 1 > ratios > FCF
-19848000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
17
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
227000
Quarters > 2 > income Statement > gross Profit
-227000
Quarters > 2 > income Statement > operating Expenses
22357000
Quarters > 2 > income Statement > operating Income
-22584000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-22275000
Quarters > 2 > income Statement > net Income
-22421000
Quarters > 2 > income Statement > eps
-0.34032618308847384
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
65880914
Quarters > 2 > income Statement > income Tax Expense
146000
Quarters > 2 > income Statement > EBITDA
-22048000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
309000
Quarters > 2 > balance Sheet > cash
37086000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
922000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
42342000
Quarters > 2 > balance Sheet > property Plant Equipment
2202000
Quarters > 2 > balance Sheet > total Assets
45736000
Quarters > 2 > balance Sheet > payables
5198000
Quarters > 2 > balance Sheet > short Term Debt
735000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
19314000
Quarters > 2 > balance Sheet > equity
26422000
Quarters > 2 > cash Flow > net Income
-22421000
Quarters > 2 > cash Flow > depreciation
227000
Quarters > 2 > cash Flow > change In Working Capital
-2551000
Quarters > 2 > cash Flow > cash From Operations
-23071000
Quarters > 2 > cash Flow > capital Expenditures
28000
Quarters > 2 > cash Flow > cash From Investing
-28000
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-22945000
Quarters > 2 > ratios > PE
-0.34032618308847384
Quarters > 2 > ratios > PB
2.0136789851790176
Quarters > 2 > ratios > ROE
-84.85731587313602
Quarters > 2 > ratios > ROA
-49.0226517404233
Quarters > 2 > ratios > FCF
-23099000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
850000
Quarters > 3 > income Statement > cost Of Revenue
219000
Quarters > 3 > income Statement > gross Profit
-219000
Quarters > 3 > income Statement > operating Expenses
26724000
Quarters > 3 > income Statement > operating Income
-26943000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-30888000
Quarters > 3 > income Statement > net Income
-31333000
Quarters > 3 > income Statement > eps
-0.47560056619736635
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
65880914
Quarters > 3 > income Statement > income Tax Expense
445000
Quarters > 3 > income Statement > EBITDA
-30669000
Quarters > 3 > income Statement > operating Margin
-3169.764705882353
Quarters > 3 > income Statement > total Other Income Expense Net
-3945000
Quarters > 3 > balance Sheet > cash
60031000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1133000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
64951000
Quarters > 3 > balance Sheet > property Plant Equipment
2363000
Quarters > 3 > balance Sheet > total Assets
67699000
Quarters > 3 > balance Sheet > payables
4661000
Quarters > 3 > balance Sheet > short Term Debt
717000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
20684000
Quarters > 3 > balance Sheet > equity
47015000
Quarters > 3 > cash Flow > net Income
-31333000
Quarters > 3 > cash Flow > depreciation
219000
Quarters > 3 > cash Flow > change In Working Capital
5188000
Quarters > 3 > cash Flow > cash From Operations
-19625000
Quarters > 3 > cash Flow > capital Expenditures
11000
Quarters > 3 > cash Flow > cash From Investing
-11000
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-20154000
Quarters > 3 > ratios > PE
-0.47560056619736635
Quarters > 3 > ratios > PB
1.1316691725279167
Quarters > 3 > ratios > ROE
-66.64468786557481
Quarters > 3 > ratios > ROA
-46.28281067667174
Quarters > 3 > ratios > FCF
-19636000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-23.101176470588236
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
849000
Annuals > 0 > income Statement > gross Profit
-849000
Annuals > 0 > income Statement > operating Expenses
94328000
Annuals > 0 > income Statement > operating Income
-95177000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-94048000
Annuals > 0 > income Statement > net Income
-95491000
Annuals > 0 > income Statement > eps
-1.449448621796595
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
65880914
Annuals > 0 > income Statement > income Tax Expense
1443000
Annuals > 0 > income Statement > EBITDA
-93199000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
1129000
Annuals > 0 > balance Sheet > cash
60031000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1133000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
64951000
Annuals > 0 > balance Sheet > property Plant Equipment
2363000
Annuals > 0 > balance Sheet > total Assets
67699000
Annuals > 0 > balance Sheet > payables
4661000
Annuals > 0 > balance Sheet > short Term Debt
717000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
20684000
Annuals > 0 > balance Sheet > equity
47015000
Annuals > 0 > cash Flow > net Income
-95491000
Annuals > 0 > cash Flow > depreciation
849000
Annuals > 0 > cash Flow > change In Working Capital
2180000
Annuals > 0 > cash Flow > cash From Operations
-82347000
Annuals > 0 > cash Flow > capital Expenditures
44000
Annuals > 0 > cash Flow > cash From Investing
-44000
Annuals > 0 > cash Flow > cash From Financing
0
Annuals > 0 > cash Flow > net Change In Cash
-83162000
Annuals > 0 > ratios > PE
-1.449448621796595
Annuals > 0 > ratios > PB
1.0083570289141763
Annuals > 0 > ratios > ROE
-203.10751887695417
Annuals > 0 > ratios > ROA
-141.0523050562047
Annuals > 0 > ratios > FCF
-82391000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
756000
Annuals > 1 > income Statement > gross Profit
-756000
Annuals > 1 > income Statement > operating Expenses
90687000
Annuals > 1 > income Statement > operating Income
-91443000
Annuals > 1 > income Statement > interest Expense
3000
Annuals > 1 > income Statement > pretax Income
-85231000
Annuals > 1 > income Statement > net Income
-86083000
Annuals > 1 > income Statement > eps
-1.9771026056606003
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
43539976
Annuals > 1 > income Statement > income Tax Expense
852000
Annuals > 1 > income Statement > EBITDA
-84475000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
6212000
Annuals > 1 > balance Sheet > cash
143193000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1127000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
147255000
Annuals > 1 > balance Sheet > property Plant Equipment
3106000
Annuals > 1 > balance Sheet > total Assets
150718000
Annuals > 1 > balance Sheet > payables
3878000
Annuals > 1 > balance Sheet > short Term Debt
655000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
17556000
Annuals > 1 > balance Sheet > equity
133162000
Annuals > 1 > cash Flow > net Income
-86083000
Annuals > 1 > cash Flow > depreciation
756000
Annuals > 1 > cash Flow > change In Working Capital
5862000
Annuals > 1 > cash Flow > cash From Operations
-71737000
Annuals > 1 > cash Flow > capital Expenditures
323000
Annuals > 1 > cash Flow > cash From Investing
-323000
Annuals > 1 > cash Flow > cash From Financing
71860000
Annuals > 1 > cash Flow > net Change In Cash
603000
Annuals > 1 > ratios > PE
-1.9771026056606003
Annuals > 1 > ratios > PB
0.23528759503161562
Annuals > 1 > ratios > ROE
-64.64531923521726
Annuals > 1 > ratios > ROA
-57.11527488422087
Annuals > 1 > ratios > FCF
-72060000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
540000
Annuals > 2 > income Statement > gross Profit
-540000
Annuals > 2 > income Statement > operating Expenses
70884000
Annuals > 2 > income Statement > operating Income
-71424000
Annuals > 2 > income Statement > interest Expense
302000
Annuals > 2 > income Statement > pretax Income
-70185000
Annuals > 2 > income Statement > net Income
-71458000
Annuals > 2 > income Statement > eps
-2.4798659682729993
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
28815267
Annuals > 2 > income Statement > income Tax Expense
1273000
Annuals > 2 > income Statement > EBITDA
-69343000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1239000
Annuals > 2 > balance Sheet > cash
142590000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1533000
Annuals > 2 > balance Sheet > inventories
-1533000
Annuals > 2 > balance Sheet > total Current Assets
148219000
Annuals > 2 > balance Sheet > property Plant Equipment
3234000
Annuals > 2 > balance Sheet > total Assets
151805000
Annuals > 2 > balance Sheet > payables
4003999
Annuals > 2 > balance Sheet > short Term Debt
515000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
12951000
Annuals > 2 > balance Sheet > equity
138854000
Annuals > 2 > cash Flow > net Income
-71458000
Annuals > 2 > cash Flow > depreciation
540000
Annuals > 2 > cash Flow > change In Working Capital
4192000
Annuals > 2 > cash Flow > cash From Operations
-59729000
Annuals > 2 > cash Flow > capital Expenditures
690000
Annuals > 2 > cash Flow > cash From Investing
-690000
Annuals > 2 > cash Flow > cash From Financing
187543000
Annuals > 2 > cash Flow > net Change In Cash
-68941000
Annuals > 2 > ratios > PE
-2.4798659682729993
Annuals > 2 > ratios > PB
0.1493328685756262
Annuals > 2 > ratios > ROE
-51.46268742708169
Annuals > 2 > ratios > ROA
-47.07223082243668
Annuals > 2 > ratios > FCF
-60419000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
41234000
Annuals > 3 > income Statement > operating Income
-41234000
Annuals > 3 > income Statement > interest Expense
361000
Annuals > 3 > income Statement > pretax Income
-67811000
Annuals > 3 > income Statement > net Income
-67879000
Annuals > 3 > income Statement > eps
-2.355660976523313
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
28815267
Annuals > 3 > income Statement > income Tax Expense
68000
Annuals > 3 > income Statement > EBITDA
-67448000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-26577000
Annuals > 3 > balance Sheet > cash
211531000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
2091000
Annuals > 3 > balance Sheet > inventories
-2091000
Annuals > 3 > balance Sheet > total Current Assets
221738000
Annuals > 3 > balance Sheet > property Plant Equipment
155000
Annuals > 3 > balance Sheet > total Assets
222288000
Annuals > 3 > balance Sheet > payables
3928000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
10364000
Annuals > 3 > balance Sheet > equity
211924000
Annuals > 3 > cash Flow > net Income
-67879000
Annuals > 3 > cash Flow > depreciation
2000
Annuals > 3 > cash Flow > change In Working Capital
-776000
Annuals > 3 > cash Flow > cash From Operations
-40646000
Annuals > 3 > cash Flow > capital Expenditures
153000
Annuals > 3 > cash Flow > cash From Investing
-153000
Annuals > 3 > cash Flow > cash From Financing
252951000
Annuals > 3 > cash Flow > net Change In Cash
208394000
Annuals > 3 > ratios > PE
-2.355660976523313
Annuals > 3 > ratios > PB
0.09784387862252505
Annuals > 3 > ratios > ROE
-32.02987863573734
Annuals > 3 > ratios > ROA
-30.536511192686966
Annuals > 3 > ratios > FCF
-40799000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.12515318492896324
Valuation > metrics > PB
59.34394086322722
Valuation > final Score
20
Valuation > verdict
1878.1% Overvalued
Profitability > metrics > ROE
-919.648737650933
Profitability > metrics > ROA
-22.747142352909233
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
42.85949506037321
Risk > metrics > Interest Coverage
-21.845372460496613
Risk > final Score
-81
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.7774117647058825
Liquidity > metrics > Quick Ratio
5.7774117647058825
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-360
Prev Risks > 1
-350
Prev Risks > 2
-432
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:40:51.991Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-04
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.2125
Earnings History > 0 > eps Difference
0.2125
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-07
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.2498
Earnings History > 1 > eps Estimate
-0.345
Earnings History > 1 > eps Difference
0.0952
Earnings History > 1 > surprise Percent
27.5942
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-14
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.4
Earnings History > 2 > eps Estimate
-0.37
Earnings History > 2 > eps Difference
-0.03
Earnings History > 2 > surprise Percent
-8.1081
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-14
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.34
Earnings History > 3 > eps Estimate
-0.31
Earnings History > 3 > eps Difference
-0.03
Earnings History > 3 > surprise Percent
-9.6774
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-27
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.48
Earnings History > 4 > eps Estimate
-0.3125
Earnings History > 4 > eps Difference
-0.1675
Earnings History > 4 > surprise Percent
-53.6
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-12
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.36
Earnings History > 5 > eps Estimate
-0.29
Earnings History > 5 > eps Difference
-0.07
Earnings History > 5 > surprise Percent
-24.1379
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-13
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.31
Earnings History > 6 > eps Estimate
-0.34
Earnings History > 6 > eps Difference
0.03
Earnings History > 6 > surprise Percent
8.8235
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-14
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.3
Earnings History > 7 > eps Estimate
-0.36
Earnings History > 7 > eps Difference
0.06
Earnings History > 7 > surprise Percent
16.6667
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-05
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.4
Earnings History > 8 > eps Estimate
-0.39
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-2.5641
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-13
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.43
Earnings History > 9 > eps Estimate
-0.44
Earnings History > 9 > eps Difference
0.01
Earnings History > 9 > surprise Percent
2.2727
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-11
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.74
Earnings History > 10 > eps Estimate
-0.66
Earnings History > 10 > eps Difference
-0.08
Earnings History > 10 > surprise Percent
-12.1212
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-11
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.59
Earnings History > 11 > eps Estimate
-0.7
Earnings History > 11 > eps Difference
0.11
Earnings History > 11 > surprise Percent
15.7143
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-14
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.7
Earnings History > 12 > eps Estimate
-0.59
Earnings History > 12 > eps Difference
-0.11
Earnings History > 12 > surprise Percent
-18.6441
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-09
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.56
Earnings History > 13 > eps Estimate
-0.67
Earnings History > 13 > eps Difference
0.11
Earnings History > 13 > surprise Percent
16.4179
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-11
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.64
Earnings History > 14 > eps Estimate
-0.68
Earnings History > 14 > eps Difference
0.04
Earnings History > 14 > surprise Percent
5.8824
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-16
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.6
Earnings History > 15 > eps Estimate
-0.66
Earnings History > 15 > eps Difference
0.06
Earnings History > 15 > surprise Percent
9.0909
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-31
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-1
Earnings History > 16 > eps Estimate
-1.02
Earnings History > 16 > eps Difference
0.02
Earnings History > 16 > surprise Percent
1.9608
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-12-17
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-36.88
Earnings History > 17 > eps Estimate
-1.6
Earnings History > 17 > eps Difference
-35.28
Earnings History > 17 > surprise Percent
-2205
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-30
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-494.09
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-494.09
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-494.09
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-494.09
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-03-31
Earnings History > 20 > report Date
2020-06-30
Earnings History > 20 > date
2020-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-70.21
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-70.21
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-31
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-70.21
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-70.21
Earnings History > 21 > surprise Percent
-
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide to target T cells that recognize epitopes derived from Arginase 1, which is an immunoregulatory enzyme highly expressed in difficult-to-treat tumors associated with high levels of myeloid-derived suppressor cells, including renal cell carcinoma, head and neck, breast, pancreatic, ovarian, colorectal, and prostate cancers. In addition, the company develops IO170, a TGFß1 vaccine for the treatment of solid tumors. IO Biotech, Inc. was incorporated in 2014 and is based in Copenhagen, Denmark.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AIO Biotech (NASDAQ: IOBT) 5-year data show 60-month OS, >53-month responses Stock Titan
Read more →What drives IOBT stock price - Stock Price Forecasts & Low Cost Capital Trading - earlytimes.in
12/14/2025
What drives IOBT stock price - Stock Price Forecasts & Low Cost Capital Trading earlytimes.in
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$2.4633
Analyst Picks
Strong Buy
2
Buy
3
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 33.77% of the total shares of IO Biotech Inc
1.
Vivo Capital, LLC(9.3706%)
since
2025/06/30
2.
HBM Healthcare Investments AG Ord(5.9873%)
since
2025/06/30
3.
Novo A/S(5.0917%)
since
2025/06/30
4.
Marshall Wace Asset Management Ltd(3.1956%)
since
2025/06/30
5.
Partner Fund Management LP(2.9934%)
since
2025/06/30
6.
Bank of America Corp(2.4515%)
since
2025/06/30
7.
Pivotal bioVenture Partners Investment Advisor LLC(1.3118%)
since
2025/06/30
8.
Morgan Stanley - Brokerage Accounts(0.9922%)
since
2025/06/30
9.
LANDSCAPE CAPITAL MANAGEMENT,LLC(0.5273%)
since
2025/06/30
10.
Dauntless Investment Group, LLC(0.4924%)
since
2025/06/30
11.
Soleus Capital Management, L.P.(0.2925%)
since
2025/06/30
12.
Renaissance Technologies Corp(0.2114%)
since
2025/06/30
13.
Sectoral Asset Management Inc(0.1786%)
since
2025/06/30
14.
Protea Sectoral Biotech Opps IF USD Acc(0.1388%)
since
2025/05/31
15.
Bridgeway Capital Management, LLC(0.1138%)
since
2025/06/30
16.
Bridgeway Ultra-Small Company Market(0.1138%)
since
2025/06/30
17.
Geode Capital Management, LLC(0.0506%)
since
2025/06/30
18.
Fidelity Nasdaq Composite Index(0.0506%)
since
2025/07/31
19.
XTX Topco Ltd(0.0443%)
since
2025/06/30
20.
Citadel Advisors Llc(0.0438%)
since
2025/06/30
21.
Jane Street Group LLC(0.0394%)
since
2025/06/30
22.
Goss Wealth Management LLC(0.0368%)
since
2025/06/30
23.
UBS Group AG(0.0201%)
since
2025/06/30
24.
Cubist Systematic Strategies, LLC(0.0199%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.2125
Date
2025-09-30
EPS Actual
-0.2498
EPS Estimate
-0.345
EPS Difference
0.0952
Surprise Percent
27.5942%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.